Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea · Delayed Price · Currency is KRW 10,860
-750 (-6.46%)
Jun 30, 2026, 3:30 PM KST
Chabiotech Market Cap
Chabiotech has a market cap or net worth of 1.07 trillion as of June 30, 2026. Its market cap has increased by 93.22% in one year.
Market Cap
1.07T
Enterprise Value
2.09T
Revenue
1.29T
Ranking
n/a
PE Ratio
n/a
Stock Price
10,860.00
Market Cap Chart
Since February 23, 2009, Chabiotech's market cap has increased from 334.13B to 1.07T, an increase of 221.41%. That is a compound annual growth rate of 6.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 1.07T | -4.06% |
| Dec 30, 2025 | 1.12T | 74.51% |
| Dec 30, 2024 | 641.46B | -41.85% |
| Dec 28, 2023 | 1.10T | 50.82% |
| Dec 29, 2022 | 731.49B | -34.83% |
| Dec 30, 2021 | 1.12T | 6.53% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Voronoi | 3.07T |
| SK bioscience | 2.74T |
| OliX Pharmaceuticals | 2.74T |
| Hugel | 2.73T |
| Orum Therapeutics | 1.07T |
| Pharmicell | 710.29B |
| GI Innovation | 623.34B |
| Onconic Therapeutics | 569.87B |